Advancing multiple myeloma therapy: A systematic analysis of corticosteroids and monoclonal antibodies as dual therapeutic agents

Table 2 Quality assessment for randomized controlled trials (Cochrane risk of bias)

Ref.	Random bias	Blinding bias	Deviations from intended interventions	Missing outcome data	Outcome measurement bias	Selective reporting bias	Overall risk of bias
Voorhees et al[10]	Low	Low	Low	Low	Low	Low	Low
Kumar et al[8]	Low	Low	Low	Low	Low	Low	Low
Lonial et al[9]	Low	Moderate	Low	Moderate	Low	Low	Moderate
Bringhen et al[4]	Low	Moderate	Low	Low	Low	Low	Low
Facon et al[7]	Low	Low	Low	Low	Low	Low	Low
Dimopoulos et al[6]	Low	Low	Low	Low	Low	Low	Low
Palumbo et al[5]	Low	Moderate	Low	Moderate	Low	Low	Moderate
Facon et al[2]	Low	Moderate	Low	Low	Low	Low	Low
Richardson et al[3]	Low	Low	Low	Low	Low	Low	Low
Rajkumar et al[1]	Low	Low	Low	Low	Low	Low	Low
Jakubowiak et al[15]	Low	Low	Low	Low	Low	Low	Low
Richardson et al[12]	Low	Low	Low	Low	Low	Low	Low
Moreau et al[20]	Low	Moderate	Low	Moderate	Low	Low	Moderate
Sonneveld et al[18]	Low	Moderate	Low	Low	Low	Low	Low
Leypoldt et al[19]	Low	Low	Low	Low	Low	Low	Low
Richardson et al[17]	Low	Low	Low	Low	Low	Low	Low
Takezako et al[16]	Low	Moderate	Low	Moderate	Low	Low	Moderate
Slade et al[23]	Low	Moderate	Low	Low	Low	Low	Low
Bringhen et al[24]	Low	Low	Low	Low	Low	Low	Low
Moreau et al[25]	Low	Low	Low	Low	Low	Low	Low
Dimopoulos et al[11]	Low	Low	Low	Low	Low	Low	Low
Mateos et al[26]	Low	Low	Low	Low	Low	Low	Low
Bahlis et al[14]	Low	Moderate	Low	Moderate	Low	Low	Moderate